Desmopressin for reducing blood transfusions in heart surgery
Part of Heart & circulation clinical trials.
This trial is testing a drug called desmopressin to see if it can reduce the need for blood transfusions in patients at high risk of bleeding during heart surgery. If you qualify, you may be randomly assigned to receive the drug or a placebo (a dummy treatment) during surgery, and the study will monitor how much blood you need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for elective heart surgery that uses a heart-lung machine.
- You have a high risk of bleeding after surgery, such as from a previous heart surgery, a bleeding disorder, kidney or liver problems, or certain blood thinners.
- You are not having combined bypass and valve surgery, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called desmopressin (DDAVP) can reduce bleeding during heart surgery. It uses a special blood test (TEG6) to decide who gets the medicine.
This trial tests if desmopressin can lower bleeding risk during a kidney transplant biopsy. It may help patients with reduced kidney function who need a biopsy.
This trial tests two medications, tranexamic acid and desmopressin, to see if they can reduce bleeding during surgery in people with severe kidney disease or on dialysis. The results may help make surgery safer for you.
This trial tests whether desmopressin can make kidney biopsy safer by reducing bleeding risk. It compares safety outcomes after a biopsy in people who meet specific blood, medication, and health criteria.
This trial studies the best way to manage blood thinning (anticoagulation) during heart surgery that uses a heart-lung machine in people with obesity. It may help reduce blood-clotting and bleeding complications by comparing different care strategies.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
Hear when a new Adult Patients Undergoing Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.